When a drug called Remdesivir showed promising signs in preliminary COVID-19 trials, the US allowed it to be used in hospitals. But around the globe, access to this new drug has been extremely difficult. In fact, it’s unclear whether huge parts of Latin America, especially, hit hard by COVID-19, will have a way to get it at all. The World’s Elana Gordon reports.
The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.
Make a gift today to help us reach our $25,000 goal and keep The World going strong. Every gift will get us one step closer.